Drugs / IN-B00009
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07308184 | Dec 2025 → Aug 2027 expected | type 2 diabetes mellitus | HK inno.N Corporation | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07192263 | Sep 2025 → Dec 2026 expected | obesity disorder | HK inno.N Corporation | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IN-B00009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07308184 ↗ |